PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma

Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359 (2015).

CAS 

Google Scholar 

Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A. & Abnet, C. C. Association between smoking and risk of bladder cancer among men and women. JAMA 306, 737 (2011).

CAS 

Google Scholar 

Lai, M. N., Wang, S. M., Chen, P. C., Chen, Y. Y. & Wang, J. D. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J. Natl. Cancer Inst. 102, 179 (2010).

CAS 

Google Scholar 

Chen, C. J., Chuang, Y. C., You, S. L., Lin, T. M. & Wu, H. Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 53, 399 (1986).

CAS 

Google Scholar 

Tsai, S. M., Wang, T. N. & Ko, Y. C. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement. J. Toxicol. Environ. Health A. 55, 389–404 (1998).

CAS 

Google Scholar 

Harling, M., Schablon, A., Schedlbauer, G., Dulon, M. & Nienhaus, A. Bladder cancer among hairdressers: A meta-analysis. Occup. Environ. Med. 67, 351 (2010).

CAS 

Google Scholar 

Zeegers, M. P., Swaen, G. M., Kant, I., Goldbohm, R. A. & van den Brandt, P. A. Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup. Environ. Med. 58, 590 (2001).

CAS 

Google Scholar 

Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64(1), 9–29 (2014).

Google Scholar 

Mitra, A. P. & Daneshmand, S. Molecular prognostication in bladder cancer. Cancer Treat Res. 175, 165 (2018).

Google Scholar 

Burger, M. et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63, 234 (2013).

Google Scholar 

Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49, 465–475 (2006).

Google Scholar 

Baumgart, S. et al. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer. J. Cancer Res. Clin. Oncol. 145, 2725 (2019).

CAS 

Google Scholar 

Pitt, J. M. et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann. Oncol. 27, 1482 (2016).

CAS 

Google Scholar 

Kalinski, P. & Talmadge, J. E. Tumor immuno-environment in cancer progression and therapy. Adv. Exp. Med. Biol. 1036, 1 (2017).

CAS 

Google Scholar 

Wang, M. et al. Role of tumor microenvironment in tumorigenesis. J. Cancer 8, 761 (2017).

CAS 

Google Scholar 

Cao, R., Yuan, L., Ma, B., Wang, G. & Tian, Y. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC). Cancer Immunol. Immunother. 70, 1 (2021).

CAS 

Google Scholar 

Sjodahl, G. et al. Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors. Urol. Oncol. 32, 791 (2014).

Google Scholar 

Hu, B. et al. Blockade of DC-SIGN(+) tumor-associated macrophages reactivates antitumor immunity and improves immunotherapy in muscle-invasive bladder cancer. Cancer Res. 80, 1707 (2020).

CAS 

Google Scholar 

Cao, J. et al. Screening and identifying immune-related cells and genes in the tumor microenvironment of bladder urothelial carcinoma: Based on TCGA database and bioinformatics. Front. Oncol. 9, 1533 (2019).

Google Scholar 

Qiao, W., Wang, H., Zhang, X. & Luo, K. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through beta-catenin signaling. Gene 681, 7 (2019).

CAS 

Google Scholar 

Zhang, H. et al. PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer. Front. Mol. Biosci. 9, 877320 (2022).

CAS 

Google Scholar 

Wang, Y. et al. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer. BMB Rep. 52, 157 (2019).

CAS 

Google Scholar 

Zhang, L. et al. Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells. Genes Dis. 5, 158 (2018).

CAS 

Google Scholar 

Zhu, J., Hu, H., Wang, J., Yang, Y. & Yi, P. PRR11 overexpression facilitates ovarian carcinoma cell proliferation, migration, and invasion through activation of the PI3K/AKT/beta-catenin pathway. Cell Physiol. Biochem. 49, 696 (2018).

CAS 

Google Scholar 

Ma, H., Yang, W., Wang, X. & Dai, G. PRR11 promotes proliferation and migration of colorectal cancer through activating the EGFR/ERK/AKT pathway via increasing CTHRC1. Ann. Clin. Lab. Sci. 52, 86–94 (2022).

CAS 

Google Scholar 

Olsson, H. S. et al. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. J. Pathol. Clin. Res. 8, 65–77 (2022).

Google Scholar 

Zhou, F. et al. Proline-rich protein 11 regulates epithelial-to-mesenchymal transition to promote breast cancer cell invasion. Int. J. Clin. Exp. Pathol. 7, 8692 (2014).

Google Scholar 

Lin, J. et al. A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts. Cancer Cell Int. 20, 402 (2020).

CAS 

Google Scholar 

Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314 (2017).

CAS 

Google Scholar 

Rhodes, D. R. et al. Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166 (2007).

CAS 

Google Scholar 

Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucl. Acids Res. 45, W98 (2017).

CAS 

Google Scholar 

Siemers, N. O. et al. Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors. PLoS ONE 12, e179726 (2017).

Google Scholar 

Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77, e108 (2017).

ADS 
CAS 

Google Scholar 

Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35, 4200 (2019).

CAS 

Google Scholar 

Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).

ADS 

Google Scholar 

Vasaikar, S. V., Straub, P., Wang, J. & Zhang, B. LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucl. Acids Res. 46, D956 (2018).

CAS 

Google Scholar 

Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 28, 27–30 (2000).

CAS 

Google Scholar 

Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Prot. Sci. 28, 1947–1951 (2019).

CAS 

Google Scholar 

Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucl. Acids Res. 49, D545–D551 (2021).

CAS 

Google Scholar 

Ji, Y. et al. PRR11 is a novel gene implicated in cell cycle progression and lung cancer. Int. J. Biochem. Cell Biol. 45, 645 (2013).

CAS 

Google Scholar 

Zhang, C. et al. PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC). Biochem. Biophys. Res. Commun. 458, 501 (2015).

CAS 

Google Scholar 

Oliver, A. J. et al. Tissue-dependent tumor microenvironments and their impact on immunotherapy responses. Front. Immunol. 9, 70 (2018).

Google Scholar 

Roma-Rodrigues, C., Mendes, R., Baptista, P. V. & Fernandes, A. R. Targeting tumor microenvironment for cancer therapy. Int. J. Mol. Sci. 20, 1 (2019).

Google Scholar 

Steuer, C. E. & Ramalingam, S. S. Tumor mutation burden: Leading immunotherapy to the era of precision medicine?. J. Clin. Oncol. 36, 631 (2018).

CAS 

Google Scholar 

Devarakonda, S. et al. Tumor mutation burden as a biomarker in resected non-small-cell lung cancer. J. Clin. Oncol. 36, 2995 (2018).

CAS 

Google Scholar 

Boland, C. R. & Goel, A. Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073 (2010).

CAS 

Google Scholar 

Ngambenjawong, C., Gustafson, H. H. & Pun, S. H. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv. Drug Deliv. Rev. 114, 206 (2017).

CAS 

Google Scholar 

Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222, 155 (2008).

CAS 

Google Scholar 

den Breems, N. Y. & Eftimie, R. The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes. J. Theor. Biol. 390, 23 (2016).

ADS 
MathSciNet 
MATH 

Google Scholar 

Fukunaga, A. et al. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28, e26 (2004).

Google Scholar 

Yang, Z. J. et al. Functions of dendritic cells and its association with intestinal diseases. Cells-Basel. 10, 1 (2021).

Google Scholar 

Hiraoka, N., Onozato, K., Kosuge, T. & Hirohashi, S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 12, 5423 (2006).

CAS 

Google Scholar 

Facciabene, A., Motz, G. T. & Coukos, G. T-regulatory cells: Key players in tumor immune escape and angiogenesis. Cancer Res. 72, 2162 (2012).

CAS 

Google Scholar 

Yuan, C. H. et al. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Oncotarget 6, 32138 (2015).

Google Scholar 

Bhattacharya, N. et al. Normalizing microbiota-induced retinoic acid deficiency stimulates protective CD8(+) T cell-mediated immunity in colorectal cancer. Immunity 45, 641 (2016).

CAS 

Google Scholar 

Ye, J. et al. Oxymatrine and cisplatin synergistically enhance anti-tumor immunity of CD8(+) T cells in non-small cell lung cancer. FRONT ONCOL. 8, 631 (2018).

Google Scholar 

Ino, Y. et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. 108, 914 (2013).

CAS 

Google Scholar